Simpler Grants.gov #RFA-DK-27-109

NIH Forecast: Continuation of the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) Resource Center

The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Heart, Lung, and Blood Institute (NHLBI), is forecasting a single source grant opportunity for the continuation of the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) Resource Center. - Government Buyer: - National Institutes of Health (NIH) - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) - National Heart, Lung, and Blood Institute (NHLBI) - No specific Original Equipment Manufacturers (OEMs) or commercial vendors are named in this notice - Products/Services Requested: - Continuation and operation of the CaRe-T1D Resource Center - Collection, storage, analysis, and sharing of cardiovascular tissue from organ donors with type 1 diabetes, type 2 diabetes, and without diabetes - Maintenance and expansion of a data repository - Coordination of consortium research activities - Support for research on cardiovascular disease pathogenesis in type 1 diabetes using multi-omics and molecular approaches - Unique/Notable Requirements: - Focus on health research and resource center operations - Emphasis on multi-omics and molecular research approaches - Single source competition with an estimated award of $2,000,000 - No specific products, part numbers, or OEMs required - Place of Performance: - National Institutes of Health (federal office)

Description

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Heart, Lung, and Blood Institute (NHLBI) seek to continue the Cardiovascular Repository for Type 1 Diabetes (CARE-T1D) consortium. The CARE-T1D biorepository collects, stores, and analyzes cardiovascular tissue from organ donors with type 1 diabetes, type 2 diabetes, and without diabetes. The continuation aims to maintain and expand the data repository, coordinate consortium activities, and advance research on cardiovascular disease pathogenesis in type 1 diabetes using multi-omics and molecular approaches. The goal is to improve understanding and develop therapies for cardiovascular disease in type 1 diabetes, a major cause of mortality.

View original listing